Dr. Martens PLC

AGM Information • Jul 10, 2025

National Storage Mechanism | Additional information

RNS Number : 5713Q

Dr. Martens PLC

10 July 2025

10 July 2025

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

10 JULY 2025

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 18 were proposed as Ordinary Resolutions and resolutions 19 to 22 as Special Resolutions.

Resolution		Votes For (note 1)	%	Votes Against (note 1)	%	Votes Total	Votes Withheld (note 2)	% Voting Capital Instructed
01	Receive the 2025 Annual Report and Accounts	786,076,243	100.00	34,102	0.00	786,110,345	370,385	81.35%
02	Approve the Directors' Remuneration Report	782,786,026	99.59	3,213,373	0.41	785,999,399	475,436	81.34%
03	Approve the Final Dividend	786,441,111	100.00	32,729	0.00	786,473,840	6,890	81.39%
04	Elect Ije Nwokorie	711,638,324	90.49	74,812,462	9.51	786,450,786	24,049	81.38%
05	Elect Benoit Vauchy	710,606,698	90.36	75,837,289	9.64	786,443,987	30,848	81.38%
06	Elect Robert Hanson	786,302,310	99.98	134,818	0.02	786,437,128	37,707	81.38%
07	Re-elect Giles Wilson	711,569,954	90.49	74,821,751	9.51	786,391,705	83,130	81.38%
08	Re-elect Lynne Weedall	777,807,755	98.90	8,621,954	1.10	786,429,709	45,126	81.38%
09	Re-elect Robyn Perriss	782,666,553	99.52	3,762,111	0.48	786,428,664	46,171	81.38%
10	Re-elect Andrew Harrison	782,674,150	99.52	3,768,078	0.48	786,442,228	32,607	81.38%
11	Re-elect Ian Rogers	781,923,703	99.43	4,518,525	0.57	786,442,228	32,607	81.38%
12	Re-elect Paul Mason	659,171,361	88.07	89,279,024	11.93	748,450,385	38,024,450	77.45%
13	Re-elect Tara Alhadeff	700,151,020	89.26	84,277,826	10.74	784,428,846	2,045,989	81.18%
14	Re-appoint PricewaterhouseCoopers LLP as auditor	786,339,031	99.99	54,271	0.01	786,393,302	81,533	81.38%
15	Authorise the Audit & Risk Committee to determine the Auditor's remuneration	786,364,884	99.99	43,453	0.01	786,408,337	66,498	81.38%
16	Approve the removal of the 5% dilution limit for discretionary share plans	785,386,811	99.87	1,055,301	0.13	786,442,112	38,618	81.38%
17	Authorise the Company and its subsidiaries to make political donations	785,724,771	99.92	665,753	0.08	786,390,524	90,206	81.38%
18	Authorise allotment of shares	783,312,171	99.62	2,997,814	0.38	786,309,985	170,745	81.37%
19	Authorise general disapplication of pre-emption rights*	745,894,239	94.86	40,453,577	5.14	786,347,816	127,019	81.37%
20	Authorise additional disapplication of pre-emption rights*	745,011,084	94.74	41,380,015	5.26	786,391,099	83,736	81.38%
21	Authorise purchase of own shares*	771,750,586	98.19	14,255,925	1.81	786,006,511	474,219	81.34%
22	Authorise calling of general meetings on 14 days' notice*	782,554,288	99.51	3,857,228	0.49	786,411,516	63,319	81.38%

*Special Resolution

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Independent Capital Instructed
06	Elect Robert Hanson	416,359,870	99.97	134,818	0.03	416,494,688	37,707	69.83%
08	Re-elect Lynne Weedall	407,865,315	97.93	8,621,954	2.07	416,487,269	45,126	69.83%
09	Re-elect Robyn Perriss	412,724,113	99.10	3,762,111	0.90	416,486,224	46,171	69.83%
10	Re-elect Andrew Harrison	412,731,710	99.10	3,768,078	0.90	416,499,788	32,607	69.84%
11	Re-elect Ian Rogers	411,981,263	98.92	4,518,525	1.08	416,499,788	32,607	69.84%

Notes:

1.     Votes "For" and "Against" are expressed as a percentage of votes received.

2.     A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3.     As at 6.30pm on 9 July 2025 the Company had a total of 966,341,901 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 6 and 8 to 11, was 596,399,461.

4.     In accordance with Listing Rule 6.4.2(R), copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

Enquiries

Company Secretariat

Paul Rolling, Head of Secretariat                                                                                                       +44 7584 243562

Investors and analysts                                                                       

Bethany Barnes, Director of Investor Relations                                                                             +44 7825 187465

bethany.barnes@drmartens.com

Beth Fionda, Investor Relations Manager                                                                              beth.fionda@drmartens.com

Press                                                                                                                                                    

Sodali & Co                                                                           

Ludo Baynham-Herd                                                                                                                          

Oliver Banks                                                                                                                                          drmartens@client.sodali.com

+44 207 250 1446

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. "Docs" or "DMs" were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned "1460" boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. Further information can be found at https://www.drmartensplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSFLSUSEISEIW